Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tech Transfer Roundup: Arrakis Gets Penn IP Toward Small Molecule RNA Therapies

Executive Summary

Canaan Partners-backed biotech will investigate the therapeutic potential of three-way junctions in folded RNA. UC Berkeley and Duke sign separate license agreements related to CRISPR gene-editing technology.

Advertisement

Related Content

CRISPR Therapeutics, Vertex Initiate First Industry-Sponsored Trial – What’s Next?
Start-Up Obsidian Gets $49.5m To Determine How And When To Activate CAR-T Cells
Duchenne Surprise: Sarepta Prices Exondys 51 Below Expectations

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC100058

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel